Marc H. Glickman - 16 Dec 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Reporting relationship: SVP & Chief Medical Officer
Issuer ticker: NVNO
Reported as of: 16 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Dec 2025, 17:47:02 UTC
Prior SEC filing: 20 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Dr. Marc Glickman, M.D.

Key filing fact

Marc H. Glickman filed Form 4 for enVVeno Medical Corp (NVNO) on 18 Dec 2025.

Key facts

This page summarizes Marc H. Glickman's Form 4 filing for enVVeno Medical Corp (NVNO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Dec 2025, 17:47.

Change

Previous filing in this sequence was filed on 20 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001730171 Primary reporting owner

Glickman Marc H.

Relationship: SVP & Chief Medical Officer
Address: C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE
Signature: /s/ Dr. Marc Glickman, M.D.
Signature date: 18 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVNO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,600
Date: 16 Dec 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVNO transaction Derivative

Restricted Stock Units

Other

Transaction value: $0
Shares: -100,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 16 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.